Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J DeVoss

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
The Journal of Clinical Investigation|April 17, 2008
Mechanisms of an autoimmunity syndrome in mice caused by a dominant mutation in AireMaureen A Su, Karen Giang, Kristina Zumer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2005
A suppressive oligodeoxynucleotide enhances the efficacy of myelin cocktail/IL-4-tolerizing DNA vaccination and treats autoimmune diseasePeggy P Ho, Paulo Fontoura, Michael Platten, et al.
Cell Death and Differentiation|May 14, 2016
RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injuryK Newton, D L Dugger, A Maltzman, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
The Journal of Clinical Investigation|April 17, 2008
Mechanisms of an autoimmunity syndrome in mice caused by a dominant mutation in AireMaureen A Su, Karen Giang, Kristina Zumer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2005
A suppressive oligodeoxynucleotide enhances the efficacy of myelin cocktail/IL-4-tolerizing DNA vaccination and treats autoimmune diseasePeggy P Ho, Paulo Fontoura, Michael Platten, et al.
Cell Death and Differentiation|May 14, 2016
RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injuryK Newton, D L Dugger, A Maltzman, et al.
Pageof 3